Reuters logo
BRIEF-Cynata Therapeutics initiates formal regulatory engagement for U.S. market
2017年4月18日 / 晚上11点15分 / 7 个月前

BRIEF-Cynata Therapeutics initiates formal regulatory engagement for U.S. market

April 19 (Reuters) - Cynata Therapeutics Ltd

* initiates formal regulatory engagement for us market

* Cynata expects to receive FDA’s written advice arising from pre-ind meeting by July 2017.

* granted a pre-investigational new drug meeting with united states food and drug administration (FDA) office of cell, tissue and gene therapy products Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below